Subcutaneous drug delivery and the role of the lymphatics

Research output: Contribution to journalArticleResearchpeer-review

91 Citations (Scopus)

Abstract

Subcutaneous injections are widely utilised as a delivery route for compounds with limited oral bioavailability or as a means to modify or extend the release profile. In this review, factors affecting absorption from the subcutaneous space are discussed with particular emphasis on differential drug absorption into either the underlying blood or lymphatic capillaries. Formulation and targeted delivery approaches, which utilise the subcutaneous administration route, are reviewed with reference to associated technologies and future challenges. © 2005 Elsevier Ltd. All rights reserved.

Original languageEnglish
Pages (from-to)89-96
Number of pages8
JournalDrug Discovery Today: Technologies
Volume2
Issue number1
DOIs
Publication statusPublished - 2005

Cite this

@article{b697e32263624cdbb926ecbe1eceda14,
title = "Subcutaneous drug delivery and the role of the lymphatics",
abstract = "Subcutaneous injections are widely utilised as a delivery route for compounds with limited oral bioavailability or as a means to modify or extend the release profile. In this review, factors affecting absorption from the subcutaneous space are discussed with particular emphasis on differential drug absorption into either the underlying blood or lymphatic capillaries. Formulation and targeted delivery approaches, which utilise the subcutaneous administration route, are reviewed with reference to associated technologies and future challenges. {\circledC} 2005 Elsevier Ltd. All rights reserved.",
author = "McLennan, {Danielle N} and Porter, {Christopher John H} and Charman, {Susan A}",
year = "2005",
doi = "10.1016/j.ddtec.2005.05.006",
language = "English",
volume = "2",
pages = "89--96",
journal = "Drug Discovery Today: Technologies",
issn = "1740-6749",
publisher = "Elsevier",
number = "1",

}

Subcutaneous drug delivery and the role of the lymphatics. / McLennan, Danielle N; Porter, Christopher John H; Charman, Susan A.

In: Drug Discovery Today: Technologies, Vol. 2, No. 1, 2005, p. 89-96.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Subcutaneous drug delivery and the role of the lymphatics

AU - McLennan, Danielle N

AU - Porter, Christopher John H

AU - Charman, Susan A

PY - 2005

Y1 - 2005

N2 - Subcutaneous injections are widely utilised as a delivery route for compounds with limited oral bioavailability or as a means to modify or extend the release profile. In this review, factors affecting absorption from the subcutaneous space are discussed with particular emphasis on differential drug absorption into either the underlying blood or lymphatic capillaries. Formulation and targeted delivery approaches, which utilise the subcutaneous administration route, are reviewed with reference to associated technologies and future challenges. © 2005 Elsevier Ltd. All rights reserved.

AB - Subcutaneous injections are widely utilised as a delivery route for compounds with limited oral bioavailability or as a means to modify or extend the release profile. In this review, factors affecting absorption from the subcutaneous space are discussed with particular emphasis on differential drug absorption into either the underlying blood or lymphatic capillaries. Formulation and targeted delivery approaches, which utilise the subcutaneous administration route, are reviewed with reference to associated technologies and future challenges. © 2005 Elsevier Ltd. All rights reserved.

UR - http://www.scopus.com/inward/record.url?scp=21744451953&partnerID=8YFLogxK

U2 - 10.1016/j.ddtec.2005.05.006

DO - 10.1016/j.ddtec.2005.05.006

M3 - Article

VL - 2

SP - 89

EP - 96

JO - Drug Discovery Today: Technologies

JF - Drug Discovery Today: Technologies

SN - 1740-6749

IS - 1

ER -